|
End-of-day quote
Shenzhen S.E.
22/09/2026
|
5-day change | 1st Jan Change | ||
| 5.910 CNY | -0.17% |
|
+6.10% | -19.81% |
| 25/08 | Beijing SL Pharmaceutical Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| 02/06 | Beijing SL Pharmaceutical Co., Ltd. Approves Cash Dividend for 2025 | CI |
| Market Cap | 593.81Cr 89Cr 77Cr 73Cr 66Cr 124.67Cr 8.47TCr 124.7Cr 873.65Cr 337.12Cr 4.33TCr 332.83Cr 325.54Cr 14TCr | P/E 2024 |
-107x | P/E 2025 | -21.7x |
|---|---|---|---|---|---|
| Enterprise Value | 479.68Cr 72Cr 63Cr 59Cr 54Cr 100.71Cr 6.84TCr 100.73Cr 705.73Cr 272.32Cr 3.5TCr 268.86Cr 262.97Cr 11TCr | EV / Sales 2024 |
8.62x | EV / Sales 2025 | 10.3x |
| Free-Float |
59.02% | Yield 2024 |
0.27% | Yield 2025 | 0.14% |
| 1 day | -0.17% | ||
| 1 week | +6.10% | ||
| Current month | -1.17% | ||
| 1 month | -16.53% | ||
| 3 months | +17.26% | ||
| 6 months | +1.37% | ||
| Current year | -19.81% |
| 1 week | 5.51 |  | 5.99 |
| 1 month | 5.5 | | 7.08 |
| Current year | 4.81 | | 9.4 |
| 1 year | 4.81 | | 9.4 |
| 3 years | 4.81 | | 16.09 |
| 5 years | 4.81 | | 16.09 |
| 10 years | 4.81 | | 33.03 |
| Manager | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CEO | Chief Executive Officer | 62 | 11/04/2006 |
Shu Jie Liang
SEC | Corporate Secretary | 60 | 11/04/2006 |
| Director | Title | Age | Since |
|---|---|---|---|
Ming Bo Xu
CHM | Chairman | 62 | 11/04/2006 |
Shu Jie Liang
BRD | Director/Board Member | 60 | 24/04/2009 |
Yan Ming Qi
CHM | Chairman | 56 | 28/05/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 05/11/25 | Buy | Director | 100 | 0.0000% | ||
| 29/10/25 | Sell | Director | 35,100 | 0.0041% | ||
| 28/10/25 | Sell | Director | 3,40,000 | 0.0399% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.17% | +6.10% | -18.71% | -36.72% | 91Cr | |
| -0.82% | +2.41% | +56.00% | +110.99% | 1,04300Cr | |
| +0.18% | +1.48% | +53.60% | +69.25% | 65TCr | |
| +0.10% | +1.98% | +20.26% | +73.11% | 47TCr | |
| 0.00% | +0.80% | +37.78% | +46.42% | 35TCr | |
| +0.73% | +3.36% | +21.12% | +27.70% | 27TCr | |
| -1.63% | +3.36% | +11.42% | +12.06% | 26TCr | |
| -0.70% | +9.33% | +43.47% | +54.19% | 22TCr | |
| -0.47% | +3.66% | +33.81% | +104.57% | 19TCr | |
| -2.01% | -6.66% | -32.05% | -60.07% | 18TCr | |
| Average | -0.43% | +2.59% | +22.67% | +40.15% | 36.34TCr | |
| Weighted average by Cap. | -0.36% | +2.19% | +37.20% | +66.95% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 66Cr 9.86Cr 8.61Cr 8.1Cr 7.39Cr 14Cr 942.29Cr 14Cr 97Cr 37Cr 481.21Cr 37Cr 36Cr 1.55TCr | 62Cr 9.31Cr 8.13Cr 7.65Cr 6.98Cr 13Cr 889.82Cr 13Cr 92Cr 35Cr 454.41Cr 35Cr 34Cr 1.46TCr |
| Net income | -7.41Cr -1.11Cr -96.6L -90.8L -82.86L -1.56Cr -105.68Cr -1.56Cr -11Cr -4.2Cr -54Cr -4.15Cr -4.06Cr -173.98Cr | -35Cr -5.18Cr -4.53Cr -4.26Cr -3.88Cr -7.29Cr -495.38Cr -7.29Cr -51Cr -20Cr -252.98Cr -19Cr -19Cr -815.56Cr |
| Net Debt | -198.23Cr -30Cr -26Cr -24Cr -22Cr -42Cr -2.83TCr -42Cr -291.64Cr -112.54Cr -1.44TCr -111.11Cr -108.67Cr -4.66TCr | -114.13Cr -17Cr -15Cr -14Cr -13Cr -24Cr -1.63TCr -24Cr -167.92Cr -65Cr -831.62Cr -64Cr -63Cr -2.68TCr |
Employees
901
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 23/26/23 | CN¥5.780 | -2.20% | 1,95,59,130 |
| 22/26/22 | CN¥5.910 | -0.17% | 2,63,57,154 |
| 21/26/21 | CN¥5.920 | +5.34% | 3,90,01,328 |
| 18/26/18 | CN¥5.620 | +0.36% | 1,97,65,752 |
| 17/26/17 | CN¥5.600 | +0.54% | 1,08,95,050 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 002038 Stock
Select your edition
All financial news and data tailored to specific country editions
